Dr. Neha Pagidipati and Dr. C. Michael Gibson discuss how the new lipid guidelines are moving the needle on LDL lowering: earlier, lower, longer.

The recent Vesalius trial adds to the data supporting lower is better, and suggests that even lower (an achieved LDL of 45 mg/dl) may be even better.

We’re watching prevention evolve in real time. The question isn’t if to intensify, but how soon and how far.

Disclosures TBD